Daniels Eric Joseph 4/A
4/A · KIORA PHARMACEUTICALS INC · Filed Nov 22, 2021
Insider Transaction Report
Form 4/AAmended
Daniels Eric Joseph
Chief Development Officer
Transactions
- Award
Common Stock
2021-10-21+9,520→ 9,520 total
Footnotes (2)
- [F1]These shares were omitted from the Reporting Person's Form 4 filed on November 10, 2021.
- [F2]Received by the Reporting Person in connection with the acquisition by the issuer of all of the outstanding securities of Bayon Therapeutics, Inc. on October 21, 2021.